Ansun BioPharma
PrivateLast Round
Series B
Oct 14, 2019
Total Funding Raised
$215M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ansun BioPharma is a biopharmaceutical company that develops host-directed recombinant protein therapeutics to treat severe viral respiratory infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ansun BioPharma Comparables
Compare Ansun BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altesa BioSciences | 78% | |
| Synairgen plc | 77% | |
| Cocrystal Pharma Inc | 73% |
Ansun BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 14, 2019 | ||||
| Series A | May 14, 2018 | ||||
| Grant | Sep 1, 2006 |
Ansun BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B, Series A |
| Korea Investment Partners | Series B |
| Bencao Capital | Series B, Series A |
| NIH RADx | Grant |
| Next Capital | Series B |
| Junson Capital | Series B |
| LYFE Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 89% MoM.
- May 14, 2018
$85M round led by Lilly Asia Ventures
Ansun BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ansun BioPharma's valuation, stock price, and market status.
Is Ansun BioPharma a public or private company?
Ansun BioPharma is a private company.
What is the current stock price of Ansun BioPharma?
Ansun BioPharma is a private company with no public stock price. No recent secondary market data is available.
How much is Ansun BioPharma worth (valuation)?
Valuation information for Ansun BioPharma is not publicly available.
Can I buy Ansun BioPharma stock?
Ansun BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ansun BioPharma's last funding round?
Ansun BioPharma's most recent funding round was Series B on October 1, 2019.
Who are the main investors in Ansun BioPharma?
Key investors in Ansun BioPharma include Oceanpine Capital, Lilly Asia Ventures.
Will Ansun BioPharma IPO soon?
No public IPO plans have been announced for Ansun BioPharma.
How can I track Ansun BioPharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ansun BioPharma's secondary market activity and sign up for updates.